According to the Zhiyitong Finance APP, Haohai Biotec (06826) announced that the company plans to use no more than 0.4 billion yuan (including this amount) of temporarily idle raised funds for cash management, with a usage period not exceeding the construction period of the raised investment projects; within the above limits and duration, the funds can be used in a revolving manner.